corona

AMA Update 284: Mifepristone, Marburg virus, new COVID variant and RSV vaccine news with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest on the Marburg virus outbreak, new coronavirus variants XBB.1.16 and XBB.1.9.1, plus Pfizer’s RSV vaccine. Also discussing what physicians and patients need to know about Texas US District Judge Matthew Kacsmaryk’s ruling to suspend the FDA’s approval of mifepristone. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 167: Latest on the monkeypox outbreak with Andrea Garcia, JD, MPH

COVID-19 boosters this September, CDC designates monkeypox as nationally notifiable condition as outbreak continues, and new CPT codes added, as covered by AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 166: Novavax vaccine questions answered with Sandra Fryhofer, MD

Novavax vaccine dose, delivery, storage, side effects—and all the details doctors need to know with Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

AMA COVID-19 resource center for physicians: http://ama-assn.org/covid-19

Read More

AMA Update 147: FDA’s latest on J&J vaccine safety concerns and more with Andrea Garcia, JD, MPH

AMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.

Read More